http://purl.org/np/RANqKCxcsUZmefrwxh1LoPNeI8bMzneuDgcQvv3ohkbVo#Head
http://purl.org/np/RANqKCxcsUZmefrwxh1LoPNeI8bMzneuDgcQvv3ohkbVo
http://www.nanopub.org/nschema#hasAssertion
http://purl.org/np/RANqKCxcsUZmefrwxh1LoPNeI8bMzneuDgcQvv3ohkbVo#assertion
http://purl.org/np/RANqKCxcsUZmefrwxh1LoPNeI8bMzneuDgcQvv3ohkbVo
http://www.nanopub.org/nschema#hasProvenance
http://purl.org/np/RANqKCxcsUZmefrwxh1LoPNeI8bMzneuDgcQvv3ohkbVo#provenance
http://purl.org/np/RANqKCxcsUZmefrwxh1LoPNeI8bMzneuDgcQvv3ohkbVo
http://www.nanopub.org/nschema#hasPublicationInfo
http://purl.org/np/RANqKCxcsUZmefrwxh1LoPNeI8bMzneuDgcQvv3ohkbVo#pubinfo
http://purl.org/np/RANqKCxcsUZmefrwxh1LoPNeI8bMzneuDgcQvv3ohkbVo
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.nanopub.org/nschema#Nanopublication
http://purl.org/np/RANqKCxcsUZmefrwxh1LoPNeI8bMzneuDgcQvv3ohkbVo#assertion
http://purl.obolibrary.org/obo/DOID_2965
https://w3id.org/biolink/vocab/category
https://w3id.org/biolink/vocab/Disease
http://purl.org/np/RANqKCxcsUZmefrwxh1LoPNeI8bMzneuDgcQvv3ohkbVo#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#object
http://purl.obolibrary.org/obo/DOID_2965
http://purl.org/np/RANqKCxcsUZmefrwxh1LoPNeI8bMzneuDgcQvv3ohkbVo#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate
https://w3id.org/biolink/vocab/treats
http://purl.org/np/RANqKCxcsUZmefrwxh1LoPNeI8bMzneuDgcQvv3ohkbVo#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
https://identifiers.org/drugbank:DB00788
http://purl.org/np/RANqKCxcsUZmefrwxh1LoPNeI8bMzneuDgcQvv3ohkbVo#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement
http://purl.org/np/RANqKCxcsUZmefrwxh1LoPNeI8bMzneuDgcQvv3ohkbVo#association
http://www.w3.org/2000/01/rdf-schema#label
carefully consider the potential benefits and risks of naprosyn ec naprosyn anaprox anaprox ds or naprosyn suspension and other treatment options before deciding to use naprosyn ec naprosyn anaprox anaprox ds or naprosyn suspension use the lowest effective dose for the shortest duration consistent with individual patient treatment goals see warnings naproxen as naprosyn ec naprosyn anaprox anaprox ds or naprosyn suspension is indicated for the relief of the signs and symptoms of rheumatoid arthritis for the relief of the signs and symptoms of osteoarthritis for the relief of the signs and symptoms of ankylosing spondylitis for the relief of the signs and symptoms of juvenile arthritis naproxen as naprosyn suspension is recommended for juvenile rheumatoid arthritis in order to obtain the maximum dosage flexibility based on the patient s weight naproxen as naprosyn anaprox anaprox ds and naprosyn suspension is also indicated for relief of the signs and symptoms of tendonitis for relief of the signs and symptoms of bursitis for relief of the signs and symptoms of acute gout for the management of pain for the management of primary dysmenorrhea ec naprosyn is not recommended for initial treatment of acute pain because the absorption of naproxen is delayed compared to absorption from other naproxen containing products see clinical pharmacology dosage and administration
http://purl.org/np/RANqKCxcsUZmefrwxh1LoPNeI8bMzneuDgcQvv3ohkbVo#association
https://w3id.org/biolink/vocab/association_type
https://w3id.org/biolink/vocab/ChemicalToDiseaseOrPhenotypicFeatureAssociation
http://purl.org/np/RANqKCxcsUZmefrwxh1LoPNeI8bMzneuDgcQvv3ohkbVo#association
https://w3id.org/biolink/vocab/provided_by
https://w3id.org/um/NeuroDKG
http://purl.org/np/RANqKCxcsUZmefrwxh1LoPNeI8bMzneuDgcQvv3ohkbVo#association
https://w3id.org/biolink/vocab/relation
https://w3id.org/um/neurodkg/SymptomaticReliefIndication
https://identifiers.org/drugbank:DB00788
https://w3id.org/biolink/vocab/category
https://w3id.org/biolink/vocab/Drug
http://purl.org/np/RANqKCxcsUZmefrwxh1LoPNeI8bMzneuDgcQvv3ohkbVo#provenance
http://purl.org/np/RANqKCxcsUZmefrwxh1LoPNeI8bMzneuDgcQvv3ohkbVo#assertion
http://www.w3.org/ns/prov#wasAttributedTo
https://orcid.org/0000-0002-1468-3557
http://purl.org/np/RANqKCxcsUZmefrwxh1LoPNeI8bMzneuDgcQvv3ohkbVo#pubinfo
http://purl.org/np/RANqKCxcsUZmefrwxh1LoPNeI8bMzneuDgcQvv3ohkbVo#sig
http://purl.org/nanopub/x/hasAlgorithm
RSA
http://purl.org/np/RANqKCxcsUZmefrwxh1LoPNeI8bMzneuDgcQvv3ohkbVo#sig
http://purl.org/nanopub/x/hasPublicKey
MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB
http://purl.org/np/RANqKCxcsUZmefrwxh1LoPNeI8bMzneuDgcQvv3ohkbVo#sig
http://purl.org/nanopub/x/hasSignature
g77viwfcDTiUz9FrF8grw9me7GrDPPr4KmaO0s9NBkHDVDV8iOVSOSi5NQrlb2xP8D8DcFvYc9gyohzk6lEUhw4/8K88RWz2r4Zy3TaKIf2SDdynL/KIGn1NgMNxyuFRFbKUn4gULT8s2Y9bUsVv5DQKnxkB+tXsgvM8f8I830Q=
http://purl.org/np/RANqKCxcsUZmefrwxh1LoPNeI8bMzneuDgcQvv3ohkbVo#sig
http://purl.org/nanopub/x/hasSignatureTarget
http://purl.org/np/RANqKCxcsUZmefrwxh1LoPNeI8bMzneuDgcQvv3ohkbVo
http://purl.org/np/RANqKCxcsUZmefrwxh1LoPNeI8bMzneuDgcQvv3ohkbVo
http://purl.org/dc/terms/created
2021-06-27T21:07:02.641+02:00
http://purl.org/np/RANqKCxcsUZmefrwxh1LoPNeI8bMzneuDgcQvv3ohkbVo
http://purl.org/dc/terms/creator
https://orcid.org/0000-0002-1468-3557
http://purl.org/np/RANqKCxcsUZmefrwxh1LoPNeI8bMzneuDgcQvv3ohkbVo
https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate
http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM
http://purl.org/np/RANqKCxcsUZmefrwxh1LoPNeI8bMzneuDgcQvv3ohkbVo
https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate
http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM
http://purl.org/np/RANqKCxcsUZmefrwxh1LoPNeI8bMzneuDgcQvv3ohkbVo
https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate
http://purl.org/np/RAManV5GZI01JKzW_IPcfOXoiFTcZMmsV7qTCLkdzr4Gs